HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

6th Edition of Cardiology World Conference

September 15-17, 2025 | London, UK

September 15 -17, 2025 | London, UK
Cardio 2024

Post-mortem diagnosis of pompe disease by exome sequencing in a Moroccan family

Najlae Adadi, Speaker at Cardiovascular Conference
Professor of Medical Genetics, Morocco
Title : Post-mortem diagnosis of pompe disease by exome sequencing in a Moroccan family

Abstract:

Background: Pompe disease is an autosomal recessive lysosomal storage disorder characterized by progressive myopathy with proximal muscle weakness, respiratory muscle dysfunction, and cardiomyopathy. Its prevalence ranges between 1/9000 and 1/40,000. It is caused by compound heterozygous or homozygous mutations in the GAA gene, which encodes for the lysosomal enzyme alpha-glucosidase, required for the degrading of lysosomal glycogen.

Case presentation: In this study, we report the case of a Moroccan consanguineous family with hypertrophic cardiomyopathy and sudden cardiac deaths at an early age; our patient was a 7-month-old Moroccan girl. Whole exome sequencing identified the deleterious homozygous mutation c.236_246delCCACACAGTGC (p.Pro79ArgfsX13) of GAA gene leading to a post-mortem diagnosis of Pompe disease.

Conclusion: The identification of the genetic substrate in our patient, the daughter, confirmed the clinical diagnosis of Pompe disease and allowed us to provide appropriate genetic counseling to the family for future pregnancies.

Keywords: Post-mortem diagnosis, Pompe disease, GAA gene, Moroccan family.

Biography:

Najlae ADADI, professor at the higher institute of Nursing Professions and Health Techniques, Dakhla, Morocco (from 2022 at present). I had my PhD in medical genetics especially cardiogenectis at the faculty of medicine and pharmacy of Rabat, Morocco in 2019.

Watsapp